Minister for Enterprise, Tourism and Employment Peter Burke, and representatives from IDA Ireland, visited Athlone Laboratories to consult with key figures on a vision for Ireland’s future in the domestic manufacturing of critical medicines.
Upperton has submitted its application to the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the approval of its new 7,000 sq. ft sterile manufacturing facility.
Testo Saveris is returning to LogiPharma in April to highlight how digital environmental monitoring can help the pharmaceutical industry make its supply chains more resilient, compliant and data-driven.
Antares Vision Group will offer live demonstrations of an integrated line providing automatic denesting, inspection and labelling for prefilled syringe production at INTERPHEX NYC, Booth 2821, 21-23rd April.
In February 2025, Future Biogas and AstraZeneca launched the UK’s first unsubsidised biomethane plant at Gonerby Moor. A year on, CEO Philipp Lukas explains why it proves green gas can scale without government support.
OBN, the membership organisation whose mission is to catalyse success in the life science industry, has invited R&D companies, professionals and investors from across the life science and pharma industries to attend BioTrinity 2026 on 14-15 April.
Mark Schofield, director, R&D, and Nick Marchand, senior manager, Cytiva, share how modern filtration innovations are driving intensified bioprocessing, boosting efficiency, and supporting sustainability across emerging modalities.
